Regulator of Oligodendrocyte Maturation, Mir-219, a Potential Biomarker for MS

被引：0
|
作者：
Bruinsma, Ilona B. [1 ]
van Dijk, Marie [2 ]
van de Lisdonk, Timothy [1 ]
Haverkort, Sanne [1 ]
Runia, Tessel [3 ]
Steinman, Lawrence [4 ]
Hintzen, Rogier [3 ]
Killestein, Joep [2 ]
Verbeek, Marcel [1 ]
Teunissen, Charlotte [2 ]
de Jong, Brigit A. [2 ]
机构：
[1] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[3] Erasmus Univ, Med Ctr, Rotterdam, Netherlands
[4] Stanford Univ, Palo Alto, CA 94304 USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P001
引用
收藏
页码：11 / 11
页数：1
相关论文
共 50 条
  • [1] Regulator of oligodendrocyte maturation, miR-219, a potential biomarker for MS
    Bruinsma, Ilona B.
    van Dijk, Marie
    Bridel, Claire
    de Lisdonk, Timothy van
    Haverkort, Sanne Q.
    Runia, Tessel F.
    Steinman, Lawrence
    Hintzen, Rogier Q.
    Killestein, Joep
    Verbeek, Marcel M.
    Teunissen, Charlotte E.
    de Jong, Brigit A.
    [J]. JOURNAL OF NEUROINFLAMMATION, 2017, 14
  • [2] Regulator of oligodendrocyte maturation, miR-219, a potential biomarker for MS
    Ilona B. Bruinsma
    Marie van Dijk
    Claire Bridel
    Timothy van de Lisdonk
    Sanne Q. Haverkort
    Tessel F. Runia
    Lawrence Steinman
    Rogier Q. Hintzen
    Joep Killestein
    Marcel M. Verbeek
    Charlotte E. Teunissen
    Brigit A. de Jong
    [J]. Journal of Neuroinflammation, 14
  • [3] Decreased miR-219 expression in MS patients: Possible role of miR-219 in the pathogenesis of MS
    Bruinsma, Ilona
    Kooi, Evert-Jan
    Geurts, Jeroen
    Verbeek, Marcel
    de Jong, Brigit
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2012, 253 (1-2) : 83 - 84
  • [4] miR-219: clinical implications for MS?
    Bruinsma, I. B.
    van Vugt, S.
    ter Burg, H.
    van de Lisdonk, T.
    Kooi, E. J.
    Baranzini, S. E.
    Ji, X.
    Sobel, R. A.
    Geurts, J. J. G.
    Steinman, L.
    de Jong, B. A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 565 - 565
  • [5] Decreased miR-219 expression in MS: Clinical implications?
    Bruinsma, Ilona
    Van Vugt, Susan
    Ter Burg, Hanneke
    De Lisdonk, Timothy Van
    Kooi, Evert-jan
    Baranzini, Sergio
    Ji, Xuhuai
    Geurts, Jeroen
    Hintzen, Rogier
    Verbeek, Marcel
    Steinman, Lawrence
    De Jong, Brigit
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2014, 275 (1-2) : 111 - 111
  • [6] Dicer1 and miR-219 Are Required for Normal Oligodendrocyte Differentiation and Myelination
    Dugas, Jason C.
    Cuellar, Trinna L.
    Scholze, Anja
    Ason, Brandon
    Ibrahim, Adiljan
    Emery, Ben
    Zamanian, Jennifer L.
    Foo, Lynette C.
    McManus, Michael T.
    Barres, Ben A.
    [J]. NEURON, 2010, 65 (05) : 597 - 611
  • [7] DICER1 AND MIR-219 ARE REQUIRED FOR NORMAL OLIGODENDROCYTE DIFFERENTIATION AND MYELINATION
    Dugas, J. C.
    Cuellar, T. L.
    Scholze, A.
    Ason, B.
    Ibrahim, A.
    Emery, B.
    Zamanian, J. L.
    Foo, L. C.
    McManus, M. T.
    Barres, B. A.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2010, 115 : 36 - 36
  • [8] Over Expression of miR-219
    Bahrami, Naghmeh
    Mohamadnia, Abdolreza
    Ebrahimi-Barough, Somayeh
    [J]. MOLECULAR THERAPY, 2017, 25 (05) : 206 - 207
  • [9] miR-219 overexpressing oligodendrocyte progenitor cells for treating compression spinal cord injury
    Nazari, Bahareh
    Namjoo, Zeinab
    Moradi, Fatemeh
    Kazemi, Mansure
    Ebrahimi-Barough, Somayeh
    Sadroddiny, Esmaeil
    Ai, Jafar
    [J]. METABOLIC BRAIN DISEASE, 2021, 36 (05) : 1069 - 1077
  • [10] miR-219 overexpressing oligodendrocyte progenitor cells for treating compression spinal cord injury
    Bahareh Nazari
    Zeinab Namjoo
    Fatemeh Moradi
    Mansure Kazemi
    Somayeh Ebrahimi-Barough
    Esmaeil Sadroddiny
    Jafar Ai
    [J]. Metabolic Brain Disease, 2021, 36 : 1069 - 1077
12345